PhotoCure ASA
Company Profile
Business description
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, and the United States.
Contact
Hoffsveien 4
Oslo0275
NORT: +47 22062210
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
102
Stocks News & Analysis
stocks
The lessons behind the best performing stock over the last 80 years
stocks
10 of the cheapest global companies with wide moats
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,089.90 | 7.80 | 0.10% |
| CAC 40 | 8,114.35 | 40.37 | 0.50% |
| DAX 40 | 23,339.74 | 185.17 | 0.80% |
| Dow JONES (US) | 41,640.85 | 200.78 | -0.48% |
| FTSE 100 | 8,707.12 | 26.83 | 0.31% |
| HKSE | 24,740.57 | 595.00 | 2.46% |
| NASDAQ | 17,496.77 | 311.89 | -1.75% |
| Nikkei 225 | 37,845.42 | 448.90 | 1.20% |
| NZX 50 Index | 12,076.85 | 189.40 | -1.54% |
| S&P 500 | 5,616.75 | 58.37 | -1.03% |
| S&P/ASX 200 | 7,860.40 | 6.30 | 0.08% |
| SSE Composite Index | 3,429.76 | 3.63 | 0.11% |